Under Attorney General Ken Paxton, the Texas Attorney General's office filed legal challenges against DACA and the sale of mifepristone

Drug pricing and affordability, FDA drug approvals, clinical trial design, drug shortages, insurer coverage, pharmaceutical regulation, and medication access.